Hiltrud Brauch

21PUBLICATIONS
287CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 02, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

|Mar 18, 2024
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

Anna M Mc Laughlin, Thomas Helland, Fenja Klima

|Jan 11, 2023
Cross-Ancestry Genome-Wide Association Study Defines the Extended CYP2D6 Locus as the Principal Genetic Determinant of Endoxifen Plasma Concentrations.

Chiea Chuen Khor, Stefan Winter, Natalia Sutiman

|Oct 28, 2022
DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.

Mehdi Manoochehri, Nasim Borhani, Clarissa Gerhäuser

|Apr 23, 2022
(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian Study.

Thais Almeida, Werner Schroth, Jeanine Nardin

Pageof 4